The recent Medical-Tech-SaaS IPO had some problems in their S-1 report. I expect it to sink to "below ipo level" as the problems could show up in 1-2 quaters after IPO.
The problem is called "Medicity buyout" and hiding the price of acquision besides the main datasheet in S-1.
Second problem is that it has very slow growth.
The problem is called "Medicity buyout" and hiding the price of acquision besides the main datasheet in S-1.
Second problem is that it has very slow growth.
評論:
-10%
交易結束：目標達成:
now 32